
Ziad Mallat
@zmallat
Medical Sciences
ID: 402264580
31-10-2011 20:08:29
2,2K Tweet
621 Followers
357 Following









Just astonishing - these guys publish in Cell Metabolism that blocking CX3CL1/CX3CR1 is a novel approach for treating atherosclerosis, yet they fail to cite the seminal papers by Mallat_Lab Combadiere and Charo’s groups published back in 2003! Scientific integrity matters!



Exciting new research in aortic valve calcification ! Thrilled to have collaborated on this study recently published in Circulation Huge congratulations to sophie susen Mickaël Rosa and all your team for this impactful work! ahajournals.org/doi/10.1161/CI… PARCC-INSERM ANR - Agence nationale de la recherche


Today in Science Magazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with Sternberg Lab. 1/13 drive.google.com/file/d/1I-UbCR…



Translating T cell targeted therapies to treat cardiovascular disease. Insights from the LILACS trial. Cambridge University CambridgeCardio British Heart Foundation

Research| Case et al. report that low-dose interleukin-2 clonally expands Tregs and maintains their suppressive program by bypassing BACH2 downregulation in patients with acute coronary syndrome from the LILACS trial.Mallat_Lab Tian Zhao Ziad Mallat rdcu.be/ephaW


Proud of you too! The award recognises your work Mallat_Lab Cambridge University PARCC-INSERM British Heart Foundation McGill University mcgill.ca/lucianaward/